Concepedia

Shelley Allen

SA

Statistics

Publications

62

Citations

5.6K

H-Index

39

Active since

1982

Affiliations

University of Bristol(Current)

Frenchay Hospital

Bristol Royal Infirmary

Array BioPharma (United States)

Southmead Hospital

Shelley Allen is an author at University of Bristol specializing in life sciences, neuroscience, and neurobiology.

ORCID

Publications per year

1982–2022

62

Publications

62

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS <sup>G12D</sup> Inhibitor

Xiaolun Wang, Shelley Allen, James F. Blake et al. · Journal of Medicinal Chemistry · 2021 · 708 citations · Full text

, , +14

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

D. M. Bowen, Shelley Allen, J. S. Benton et al. · Journal of Neurochemistry · 1983 · 443 citations

, , +17

Presynaptic Cholinergic Dysfunction in Patients with Dementia

Neil R. Sims, D. M. Bowen, Shelley Allen et al. · Journal of Neurochemistry · 1983 · 420 citations

, , +16

16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain

David C. Emery, Deborah K. Shoemark, Tom Batstone et al. · Frontiers in Aging Neuroscience · 2017 · 317 citations · Full text

, , +17

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients

D. M. Bowen, J. S. Benton, J. A. Spillane et al. · Journal of the Neurological Sciences · 1982 · 198 citations

, , +16

1–5 of 62